Selected research
Industry Research
Respiratory Drug Delivery Devices Industry Research Report 2026
Market perspective
The global Respiratory Drug Delivery Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Respiratory Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Respiratory Drug Delivery Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Respiratory Drug Delivery Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Respiratory Drug Delivery Devices include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Novartis, Teva, Organon, PARI GmbH and Omron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Respiratory Drug Delivery Devices market in terms of revenue (US$ million) and, where applicable, sales volume (M units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Respiratory Drug Delivery Devices Market by Company
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
PARI GmbH
Omron
Philips
Drive DeVilbiss Healthcare
Yuwell
Leyi
Folee
Beurer
Respiratory Drug Delivery Devices Segment by Type
Metered Dose Inhalers (MDI)
Dry Powder Inhalers (DPI)
Nebulizers
Respiratory Drug Delivery Devices Segment by Application
Asthma
COPD
Others
Respiratory Drug Delivery Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Respiratory Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Respiratory Drug Delivery Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Respiratory Drug Delivery Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Respiratory Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Metered Dose Inhalers (MDI)
- Dry Powder Inhalers (DPI)
- Nebulizers
Applications
- Asthma
- COPD
- Others
Companies covered
- GSK
- AstraZeneca
- Chiesi
- Boehringer Ingelheim
- Novartis
- Teva
- Organon
- PARI GmbH
- Omron
- Philips
- Drive DeVilbiss Healthcare
- Yuwell
- Leyi
- Folee
- Beurer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Respiratory Drug Delivery Devices Market Size (2021-2032)
- 2.2.2 Global Respiratory Drug Delivery Devices Sales (2021-2032)
- 2.2.3 Global Respiratory Drug Delivery Devices Market Average Price (2021-2032)
- 2.3 Respiratory Drug Delivery Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Metered Dose Inhalers (MDI)
- 2.3.3 Dry Powder Inhalers (DPI)
- 2.3.4 Nebulizers
- 2.4 Respiratory Drug Delivery Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Asthma
- 2.4.3 COPD
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Respiratory Drug Delivery Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Respiratory Drug Delivery Devices Sales (M units) of Manufacturers (2021-2026)
- 3.3 Global Respiratory Drug Delivery Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Respiratory Drug Delivery Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Respiratory Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Respiratory Drug Delivery Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Respiratory Drug Delivery Devices, Product Type & Application
- 3.8 Global Manufacturers of Respiratory Drug Delivery Devices, Established Date
- 3.9 Global Respiratory Drug Delivery Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Respiratory Drug Delivery Devices Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 AstraZeneca
- 4.2.1 AstraZeneca Company Information
- 4.2.2 AstraZeneca Business Overview
- 4.2.3 AstraZeneca Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AstraZeneca Respiratory Drug Delivery Devices Product Portfolio
- 4.2.5 AstraZeneca Recent Developments
- 4.3 Chiesi
- 4.3.1 Chiesi Company Information
- 4.3.2 Chiesi Business Overview
- 4.3.3 Chiesi Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Chiesi Respiratory Drug Delivery Devices Product Portfolio
- 4.3.5 Chiesi Recent Developments
- 4.4 Boehringer Ingelheim
- 4.4.1 Boehringer Ingelheim Company Information
- 4.4.2 Boehringer Ingelheim Business Overview
- 4.4.3 Boehringer Ingelheim Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boehringer Ingelheim Respiratory Drug Delivery Devices Product Portfolio
- 4.4.5 Boehringer Ingelheim Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis Respiratory Drug Delivery Devices Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Teva
- 4.6.1 Teva Company Information
- 4.6.2 Teva Business Overview
- 4.6.3 Teva Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teva Respiratory Drug Delivery Devices Product Portfolio
- 4.6.5 Teva Recent Developments
- 4.7 Organon
- 4.7.1 Organon Company Information
- 4.7.2 Organon Business Overview
- 4.7.3 Organon Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Organon Respiratory Drug Delivery Devices Product Portfolio
- 4.7.5 Organon Recent Developments
- 4.8 PARI GmbH
- 4.8.1 PARI GmbH Company Information
- 4.8.2 PARI GmbH Business Overview
- 4.8.3 PARI GmbH Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 PARI GmbH Respiratory Drug Delivery Devices Product Portfolio
- 4.8.5 PARI GmbH Recent Developments
- 4.9 Omron
- 4.9.1 Omron Company Information
- 4.9.2 Omron Business Overview
- 4.9.3 Omron Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Omron Respiratory Drug Delivery Devices Product Portfolio
- 4.9.5 Omron Recent Developments
- 4.10 Philips
- 4.10.1 Philips Company Information
- 4.10.2 Philips Business Overview
- 4.10.3 Philips Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Philips Respiratory Drug Delivery Devices Product Portfolio
- 4.10.5 Philips Recent Developments
- 4.11 Drive DeVilbiss Healthcare
- 4.11.1 Drive DeVilbiss Healthcare Company Information
- 4.11.2 Drive DeVilbiss Healthcare Business Overview
- 4.11.3 Drive DeVilbiss Healthcare Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Drive DeVilbiss Healthcare Respiratory Drug Delivery Devices Product Portfolio
- 4.11.5 Drive DeVilbiss Healthcare Recent Developments
- 4.12 Yuwell
- 4.12.1 Yuwell Company Information
- 4.12.2 Yuwell Business Overview
- 4.12.3 Yuwell Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yuwell Respiratory Drug Delivery Devices Product Portfolio
- 4.12.5 Yuwell Recent Developments
- 4.13 Leyi
- 4.13.1 Leyi Company Information
- 4.13.2 Leyi Business Overview
- 4.13.3 Leyi Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Leyi Respiratory Drug Delivery Devices Product Portfolio
- 4.13.5 Leyi Recent Developments
- 4.14 Folee
- 4.14.1 Folee Company Information
- 4.14.2 Folee Business Overview
- 4.14.3 Folee Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Folee Respiratory Drug Delivery Devices Product Portfolio
- 4.14.5 Folee Recent Developments
- 4.15 Beurer
- 4.15.1 Beurer Company Information
- 4.15.2 Beurer Business Overview
- 4.15.3 Beurer Respiratory Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Beurer Respiratory Drug Delivery Devices Product Portfolio
- 4.15.5 Beurer Recent Developments
5 Global Respiratory Drug Delivery Devices Market Scenario by Region
- 5.1 Global Respiratory Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Respiratory Drug Delivery Devices Sales by Region: 2021-2032
- 5.2.1 Global Respiratory Drug Delivery Devices Sales by Region: 2021-2026
- 5.2.2 Global Respiratory Drug Delivery Devices Sales by Region: 2027-2032
- 5.3 Global Respiratory Drug Delivery Devices Revenue by Region: 2021-2032
- 5.3.1 Global Respiratory Drug Delivery Devices Revenue by Region: 2021-2026
- 5.3.2 Global Respiratory Drug Delivery Devices Revenue by Region: 2027-2032
- 5.4 North America Respiratory Drug Delivery Devices Market Facts & Figures by Country
- 5.4.1 North America Respiratory Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Respiratory Drug Delivery Devices Sales by Country (2021-2032)
- 5.4.3 North America Respiratory Drug Delivery Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Respiratory Drug Delivery Devices Market Facts & Figures by Country
- 5.5.1 Europe Respiratory Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Respiratory Drug Delivery Devices Sales by Country (2021-2032)
- 5.5.3 Europe Respiratory Drug Delivery Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Respiratory Drug Delivery Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Respiratory Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Respiratory Drug Delivery Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Respiratory Drug Delivery Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Respiratory Drug Delivery Devices Market Facts & Figures by Country
- 5.7.1 South America Respiratory Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Respiratory Drug Delivery Devices Sales by Country (2021-2032)
- 5.7.3 South America Respiratory Drug Delivery Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Respiratory Drug Delivery Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Respiratory Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Respiratory Drug Delivery Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Respiratory Drug Delivery Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Respiratory Drug Delivery Devices Sales by Type (2021-2032)
- 6.1.1 Global Respiratory Drug Delivery Devices Sales by Type (2021-2032) & (M units)
- 6.1.2 Global Respiratory Drug Delivery Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Respiratory Drug Delivery Devices Revenue by Type (2021-2032)
- 6.2.1 Global Respiratory Drug Delivery Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Respiratory Drug Delivery Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Respiratory Drug Delivery Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Respiratory Drug Delivery Devices Sales by Application (2021-2032)
- 7.1.1 Global Respiratory Drug Delivery Devices Sales by Application (2021-2032) & (M units)
- 7.1.2 Global Respiratory Drug Delivery Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Respiratory Drug Delivery Devices Revenue by Application (2021-2032)
- 7.2.1 Global Respiratory Drug Delivery Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Respiratory Drug Delivery Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Respiratory Drug Delivery Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Respiratory Drug Delivery Devices Value Chain Analysis
- 8.1.1 Respiratory Drug Delivery Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Respiratory Drug Delivery Devices Production Mode & Process
- 8.2 Respiratory Drug Delivery Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Respiratory Drug Delivery Devices Distributors
- 8.2.3 Respiratory Drug Delivery Devices Customers
9 Global Respiratory Drug Delivery Devices Analyzing Market Dynamics
- 9.1 Respiratory Drug Delivery Devices Industry Trends
- 9.2 Respiratory Drug Delivery Devices Industry Drivers
- 9.3 Respiratory Drug Delivery Devices Industry Opportunities and Challenges
- 9.4 Respiratory Drug Delivery Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst